Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations
Min Hyung Ryu(Brigham and Women's Hospital), Craig P. Hersh(Brigham and Women's Hospital), Robert Chase, Russell P. Bowler(Cleveland Clinic), Igor Barjaktarević, Jeong H. Yun, Meryl Stav, Yvonne J. Huang(University of Wisconsin–Madison), Wassim W. Labaki(Michigan Medicine), Aabida Saferali(Brigham and Women's Hospital), Don D. Sin(University of British Columbia), Jeffrey L. Curtis(VA Ann Arbor Healthcare System), Wanda K. O’Neal(University of North Carolina at Chapel Hill), Peter J. Castaldi(Brigham and Women's Hospital), Zhonghui Xu(Zhejiang Chinese Medical University), Meilan Han(Pulmonary and Critical Care Associates), Jarrett D. Morrow, S. Christenson(University of California, San Francisco), Christine M. Freeman(University of Michigan)
Cited by 27
Related Papers
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Muc5b is required for airway defence
|Nature|2013|777
Lung adenocarcinoma promotion by air pollutants
|Nature|2023|751
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
|Canadian Respiratory Journal|2007|685
Variants in FAM13A are associated with chronic obstructive pulmonary disease
|Nature Genetics|2010|423